Literature DB >> 23598950

Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia.

Oriol Sibila1, Eric M Mortensen, Antonio Anzueto, Elena Laserna, Marcos I Restrepo.   

Abstract

There is controversy regarding the impact of chronic obstructive pulmonary disease (COPD) in clinical outcomes in elderly patients with pneumonia. Comorbidities such as cardiovascular disease have been reported to play an important role in patients with acute exacerbations of COPD. However, limited data are available regarding the impact of cardiovascular disease in elderly COPD patients who require hospitalisation for pneumonia. We examined a cohort of subjects with pneumonia and pre-existing COPD. Prior cardiovascular disease was defined as history of myocardial infarction, congestive heart failure, cardiac arrhythmia, unstable angina or stroke. Outcomes examined included 30-day, 90-day, 6-month and 1-year mortality. We included 17,140 elderly COPD patients who were hospitalised for pneumonia. Prior cardiovascular disease was present in 10 240 (59.7%) patients. Prior cardiovascular disease was independently associated with 90-day mortality (21.3% versus 19.4%; hazard ratio (HR) 1.29, 95% CI 1.02-1.17), 6-month mortality (29.0% versus 26.1%; HR 1.28, 95% CI 1.07-1.50) and 12-month mortality (39.2% versus 34.5%; HR 1.33, 95% CI 1.15-1.54) when compared to no prior cardiovascular disease. The temporal differential effect between groups increases from 1.0% at 30 days to 4.7% at 1 year. Prior cardiovascular disease is associated with increased long-term mortality in elderly COPD patients with pneumonia. Differences in mortality rates increased over time.

Entities:  

Mesh:

Year:  2013        PMID: 23598950      PMCID: PMC4066656          DOI: 10.1183/09031936.00117312

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  31 in total

1.  Medium-term survival after hospitalization with community-acquired pneumonia.

Authors:  Grant W Waterer; Lori A Kessler; Richard G Wunderink
Journal:  Am J Respir Crit Care Med       Date:  2003-12-23       Impact factor: 21.405

2.  Deaths: final data for 2008.

Authors:  Arialdi M Miniño; Sherry L Murphy; Jiaquan Xu; Kenneth D Kochanek
Journal:  Natl Vital Stat Rep       Date:  2011-12-07

3.  Acute exacerbation of COPD: factors associated with poor treatment outcome.

Authors:  N A Dewan; S Rafique; B Kanwar; H Satpathy; K Ryschon; G S Tillotson; M S Niederman
Journal:  Chest       Date:  2000-03       Impact factor: 9.410

4.  COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program.

Authors:  Stephen Sidney; Michael Sorel; Charles P Quesenberry; Cynthia DeLuise; Stephan Lanes; Mark D Eisner
Journal:  Chest       Date:  2005-10       Impact factor: 9.410

5.  Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia.

Authors:  Eric M Mortensen; Wishwa N Kapoor; Chung-Chou H Chang; Michael J Fine
Journal:  Clin Infect Dis       Date:  2003-11-20       Impact factor: 9.079

6.  Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice.

Authors:  Morteza Naghavi; Philip Wyde; Silvio Litovsky; Mohammad Madjid; Adeeba Akhtar; Sameh Naguib; Mir Said Siadaty; Susan Sanati; Ward Casscells
Journal:  Circulation       Date:  2003-02-11       Impact factor: 29.690

7.  Procalcitonin in acute myocardial infarction.

Authors:  Nikolaos Kafkas; Kiriaki Venetsanou; Sotirios Patsilinakos; Vasilios Voudris; Dionisios Antonatos; Kostas Kelesidis; George Baltopoulos; Peter Maniatis; Dennis V Cokkinos
Journal:  Acute Card Care       Date:  2008

8.  Influence of comorbid conditions on long-term mortality after pneumonia in older people.

Authors:  Sachin Yende; Derek C Angus; Ibrahim Sultan Ali; Grant Somes; Anne B Newman; Douglas Bauer; Melissa Garcia; Tamara B Harris; Stephen B Kritchevsky
Journal:  J Am Geriatr Soc       Date:  2007-04       Impact factor: 5.562

9.  Validation of a combined comorbidity index.

Authors:  M Charlson; T P Szatrowski; J Peterson; J Gold
Journal:  J Clin Epidemiol       Date:  1994-11       Impact factor: 6.437

10.  The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease.

Authors:  Colin R Cooke; Min J Joo; Stephen M Anderson; Todd A Lee; Edmunds M Udris; Eric Johnson; David H Au
Journal:  BMC Health Serv Res       Date:  2011-02-16       Impact factor: 2.655

View more
  12 in total

1.  Association of COPD With Risk for Pulmonary Infections Requiring Hospitalization in HIV-Infected Veterans.

Authors:  Engi F Attia; Kathleen A McGinnis; Laura C Feemster; Kathleen M Akgün; Adeel A Butt; Christopher J Graber; Michael J Fine; Matthew B Goetz; Maria C Rodriguez-Barradas; Margaret A Pisani; Hilary A Tindle; Sheldon T Brown; Guy W Soo Hoo; David Rimland; Cynthia L Gibert; Laurence Huang; Matthew S Freiberg; Catherine L Hough; Kristina Crothers
Journal:  J Acquir Immune Defic Syndr       Date:  2015-11-01       Impact factor: 3.731

Review 2.  Year in review 2016: Respiratory infections, acute respiratory distress syndrome, pleural diseases, lung cancer and interventional pulmonology.

Authors:  Marcos I Restrepo; James D Chalmers; Yuanlin Song; Christopher Mallow; Justin Hewlett; Fabien Maldonado; Lonny Yarmus
Journal:  Respirology       Date:  2017-02-28       Impact factor: 6.424

3.  Community-acquired pneumonia in patients with chronic obstructive pulmonary disease.

Authors:  Aykut Cilli
Journal:  Curr Infect Dis Rep       Date:  2015-01       Impact factor: 3.725

4.  Corticosteroids for severe CAP: the pros.

Authors:  Antoni Torres
Journal:  Rev Bras Ter Intensiva       Date:  2015 Jul-Sep

5.  Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease.

Authors:  Sheng-Hao Lin; Diahn-Warng Perng; Ching-Pei Chen; Woei-Horng Chai; Chin-Shui Yeh; Chew-Teng Kor; Shih-Lung Cheng; Jeremy Jw Chen; Ching-Hsiung Lin
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-12-05

6.  Efficacy and safety of glucocorticoids in the treatment of severe community-acquired pneumonia: A meta-analysis.

Authors:  Shan Jiang; Tiecheng Liu; Yuxin Hu; Ranwei Li; Xin Di; Xin Jin; Yanqiao Wang; Ke Wang
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

7.  RDW-based clinical score to predict long-term survival in community-acquired pneumonia: a European derivation and validation study.

Authors:  Remo Melchio; Jacopo Davide Giamello; Elisa Testa; Luis Alberto Ruiz Iturriaga; Andrea Falcetta; Cristina Serraino; Piero Riva; Christian Bracco; Leyre Serrano Fernandez; Salvatore D'Agnano; Stefano Leccardi; Massimo Porta; Luigi Maria Fenoglio
Journal:  Intern Emerg Med       Date:  2021-01-11       Impact factor: 3.397

8.  Incidence and cost of pneumonia in older adults with COPD in the United States.

Authors:  Marian Ryan; Jose A Suaya; John D Chapman; William B Stason; Donald S Shepard; Cindy Parks Thomas
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

Review 9.  Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease.

Authors:  Antoni Torres; Francesco Blasi; Nathalie Dartois; Murat Akova
Journal:  Thorax       Date:  2015-07-28       Impact factor: 9.139

10.  Risk of exacerbation following pneumonia in adults with heart failure or chronic obstructive pulmonary disease.

Authors:  Rebecca Bornheimer; Kimberly M Shea; Reiko Sato; Derek Weycker; Stephen I Pelton
Journal:  PLoS One       Date:  2017-10-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.